GSK U.S. Clinical Trial Registry Will Publicize Studies For Marketed Products

The registry appears to build upon an initiative launched by Glaxo Wellcome in 1998; that registry was only available to health care providers. The announcement closely follows the New York AG's lawsuit on Paxil study data, but GSK says the program has been under consideration for several months.